Heterodimeric ligands of the estrogen receptor as potential anti-breast cancer agents.

A Knox, N Fahrner, Daniela Brigitte Schuster, R Gust

    Research output: Contribution to conferenceunpublished Abstract

    Original languageEnglish
    Publication statusPublished - 2017
    EventPharma 2030 - Current and Future Challenges (ÖPhG) - University of Innsbruck, Austria
    Duration: 20 Apr 201722 Apr 2017

    Conference with scientific content

    Conference with scientific contentPharma 2030 - Current and Future Challenges (ÖPhG)
    Country/TerritoryAustria
    CityUniversity of Innsbruck
    Period20/04/1722/04/17

    Cite this